Eggermont Am

EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

Eggermont Am, Stefan Suciu, Mario Santinami et al. · Research Explorer (The University of Manchester) · 2008 · 111 citations

Surgical Oncology, Eortc Melanoma Group, Medicine +9

Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study.

D. Liénard, Eggermont Am, Schraffordt Koops H et al. · PubMed · 1994 · 95 citations

Isolated Perfusion, Melanoma Stage Iii, Medicine +12

Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion.

Klaase Jm, Kroon Bb, van Geel An et al. · PubMed · 1994 · 60 citations

Local regional promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine activated killer cells.

Eggermont Am, Steller Ep, Marquet Rl et al. · PubMed · 1988 · 60 citations

Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.

Eggermont Am, Willem Weimar, Marquet Rl et al. · PubMed · 1985 · 19 citations

Surgical Oncology, Phase Ii Trial, Gastrointestinal Oncology +14